6533b81ffe1ef96bd1278350

RESEARCH PRODUCT

Sodium oxybate therapy for the treatment of alcohol withdrawal syndrome and the maintenance of alcohol abstinence

Carmen MannucciSimona PichiniElvira Ventura SpagnoloFabrizio CalapaiSebastiano GangemiMichele NavarraGioacchino Calapai

subject

gamma-hydroxybutyrateGHB; alcohol abstinence.; alcohol withdrawal; gamma-hydroxybutyrate; gamma-hydroxybutyric acid; sodium oxybateSettore MED/43 - Medicina Legalealcohol abstinence.alcohol withdrawalgamma-hydroxybutyric acidSettore BIO/14 - FarmacologiaGHBsodium oxybate

description

Gamma-hydroxybutyrate (GHB or sodium oxybate) is both an exogenous and endogenous molecule with neuromodulator properties. In the United States, GHB is an approved drug for the treatment of narcolepsy and narcolepsy with cataplexy in adults. In some European Union countries, sodium oxybate is applied for the treatment of opioid and alcohol withdrawal.

yearjournalcountryeditionlanguage
2017-01-01
10.2174/1389200219666171207122227http://hdl.handle.net/10447/281941